TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
75.48
+2.57 (3.52%)
At close: Jun 15, 2026, 4:00 PM EDT
75.08
-0.40 (-0.53%)
After-hours: Jun 15, 2026, 7:55 PM EDT
TransMedics Group Employees
TransMedics Group had 898 employees as of December 31, 2025. The number of employees increased by 170 or 23.35% compared to the previous year.
Employees
898
Change (1Y)
170
Growth (1Y)
23.35%
Revenue / Employee
$708,118
Profits / Employee
$191,452
Market Cap
2.61B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 898 | 170 | 23.35% |
| Dec 31, 2024 | 728 | 144 | 24.66% |
| Dec 31, 2023 | 584 | 372 | 175.47% |
| Dec 31, 2022 | 212 | 64 | 43.24% |
| Dec 31, 2021 | 148 | 38 | 34.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 29, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Integer Holdings | 11,000 |
| UFP Technologies | 4,846 |
| LivaNova | 3,300 |
| Haemonetics | 3,009 |
| Neogen | 2,974 |
| iRhythm Holdings | 2,400 |
| NovoCure | 1,605 |
| Establishment Labs Holdings | 1,004 |
TMDX News
- 3 days ago - Johnson Fistel Investigates TransMedics Group, Inc. (TMDX) After Recent Disclosures Concerning Margin Pressure and NOP Investments - GlobeNewsWire
- 13 days ago - TransMedics Group Transcript: 46th Annual William Blair Growth Stock Conference - Transcripts
- 20 days ago - TransMedics price target lowered to $75 from $85 at Stifel - TheFly
- 25 days ago - TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 27 days ago - TransMedics to Present at the William Blair 46th Annual Growth Stock Conference - PRNewsWire
- 5 weeks ago - TransMedics Group Proxy statement: Proxy filing - Filings
- 5 weeks ago - TransMedics downgraded to Perform from Outperform at Oppenheimer - TheFly
- 5 weeks ago - TransMedics price target lowered to $140 from $157 at Baird - TheFly